This study aims to evaluate the concentrations of U-II and TGF-β in individuals with COPD, as well as in healthy smokers and non-smokers, to explore their potential roles in COPD-related fibrosis. This evidence concerns the gene TGFB1 and chronic obstructive pulmonary disease.